Founded in April 2000. Discovery and development of small molecules active on novel G protein-coupled receptors. CHF38 Mio raised, 60 employees. Most advanced project (Phase II): sub-arachnoid haemorrhage. Acquired by Actelion (ATLN) in October 2003.

Company Info
Country: Switzerland
Industry:    Biotech
Sector: biotechnology
Status: Realized
Vehicle: Genevest

Company website

Endeavour Vision Team
Sven Lingjaerde
© Endeavour Vision SA 2006-2017 Terms & Conditions